tiprankstipranks
Trending News
More News >
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Contineum Therapeutics, Inc. Class A (CTNM) Similar Stocks

Compare
166 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$3.56
$92.23M
-77.38%
4 Buy
0 Hold
0 Sell
Strong Buy
Lineage Therap
$0.70
$159.55M
-33.52%
4 Buy
0 Hold
0 Sell
Strong Buy
Enanta Pharmaceuticals
$5.81
$124.20M
-51.90%
2 Buy
1 Hold
0 Sell
Moderate Buy
Cellectis SA
$1.47
$116.07M
-47.87%
2 Buy
2 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$7.67
$66.98M
-57.76%
2 Buy
2 Hold
0 Sell
Moderate Buy
Champions Oncology
$5.80
$80.20M
12.88
28.32%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
3.56
-11.14
-75.78%
LCTX
Lineage Therap
0.70
-0.28
-28.57%
ENTA
Enanta Pharmaceuticals
5.81
-6.12
-51.30%
CLLS
Cellectis SA
1.47
-1.31
-47.12%
MCRB
Seres Therapeutics
7.67
-10.92
-58.74%
CSBR
Champions Oncology
5.80
1.23
26.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis